Table 2 Characteristics of the propensity score matched pairs
Monthly Visit (n = 696) | Bimonthly Visit (n = 696) | Absolute Standardized Difference, % | P Value | |
|---|---|---|---|---|
Demographics | ||||
Age | 66.3 ± 5.0 | 66.3 ± 5.1 | 0.3 | 0.95 |
Gender (female) | 329 (47.5) | 334 (48.2) | 1.4 | 0.79 |
BMI | 23.4 ± 3.0 | 23.4 ± 3.2 | 0.4 | 0.93 |
Current smoker | 63 (9.1) | 71 (10.3) | 3.7 | 0.47 |
Regular exercise | 334 (48.2) | 348 (50.2) | 4.0 | 0.45 |
Daily alcohol intake | 141 (20.4) | 150 (21.7) | 3.2 | 0.97 |
Sleep well | 595 (85.9) | 598 (86.3) | 1.3 | 0.82 |
Skip breakfast more than three times in a week | 20 (2.9) | 21 (3.0) | 0.8 | 0.87 |
Medication | ||||
Antihypertensive Drugs | 363 (52.4) | 344 (49.6) | 5.6 | 0.31 |
Oral Blood Glucose Lowering Drugs | 430 (62.0) | 414 (59.7) | 5.0 | 0.35 |
Lipid Lowering Drugs | 292 (42.1) | 281 (40.6) | 3.2 | 0.55 |
Medical History | ||||
History of celebrovascular diseases | 38 (5.5) | 40 (5.8) | 1.3 | 0.82 |
History of heart diseases | 92 (13.3) | 84 (12.1) | 3.7 | 0.52 |
History of renal failure | 0 (0.0) | 1 (0.1) | 2.5 | 0.32 |
CKD | ||||
stage 1 | 64 (9.2) | 70 (10.1) | 2.6 | 0.59 |
stage 2 | 492 (71.0) | 498 (71.9) | 1.9 | 0.72 |
stage 3 | 136 (19.6) | 122 (17.6) | 5.4 | 0.33 |
stage 4 | 1 (0.1) | 2 (0.3) | 2.5 | 0.56 |
stage 5 | 0 (0.0) | 1 (0.1) | 4.6 | 0.32 |
Systlic Blood Pressure (mmHg) | 129.6 ± 15.6 | 129.7 ± 15.9 | 1.0 | 0.86 |
Diastlic Blood Pressure (mmHg) | 74.8 ± 9.6 | 74.7 ± 9.8 | 0.9 | 0.87 |
HbA1c (%) | 6.0 ± 0.5 | 6.0 ± 0.5 | 2.6 | 0.71 |
LDL (mg/dl) | 118.0 ± 27.1 | 119.2 ± 28.8 | 4.5 | 0.40 |
HDL (mg/dl) | 59.3 ± 14.7 | 59.2 ± 15.0 | 0.3 | 0.95 |
TG (mg/dl) | 121.2 ± 66.8 | 123.2 ± 69.9 | 2.8 | 0.59 |
GOT (IU/L) | 24.2 ± 8.2 | 24.6 ± 9.4 | 4.3 | 0.37 |
GPT (IU/L) | 22.3 ± 11.5 | 23.3 ± 14.3 | 6.7 | 0.18 |
G-GTP (IU/L) | 34.4 ± 36.1 | 35.9 ± 37.5 | 4.1 | 0.43 |
Uric acid (mg/dl) | 5.5 ± 1.3 | 5.5 ± 1.3 | 0.8 | 0.88 |
eGFR (mL/min/1.73 m2) | 71.6 ± 13.6 | 72.1 ± 14.9 | 2.9 | 0.57 |
Albmin (g/dl) | 4.3 ± 0.3 | 4.3 ± 0.3 | 0.8 | 0.88 |
Hemoglobin (g/dl) | 14.0 ± 1.3 | 14.0 ± 1.4 | 0.7 | 0.89 |